NASP Applauds Senate Action on Specialty Pharmacy Legislation
The National Association of Specialty Pharmacy (NASP) recently expressed its support for the bipartisan legislation introduced by the Senate Finance Committee. This significant move targets anticompetitive practices that threaten beneficiary access to their desired specialty pharmacies. The new legislation aims to enhance and enforce the existing federal Any Willing Pharmacy law, ensuring that pharmacies are granted fair and relevant Part D contract terms, which is crucial for their sustainability.
Key Reforms Benefiting Specialty Pharmacies
The proposed reforms align closely with NASP's long-term objectives to protect specialty pharmacies while ensuring patient access to necessary medications. If this bill is enacted, it will compel the Administration to require that contracts among health plans, pharmacy benefit managers (PBMs), and specialty pharmacies operating under Medicare Part D include reasonable and relevant terms. Notably, the legislation would also ban PBMs from employing spread pricing within Medicaid, bringing forth essential payment protections that enhance the viability of pharmacies and safeguard access for patients.
The Importance of Specialty Pharmacies for Patients
These legislative enactments are vital for ensuring that Medicare and Medicaid beneficiaries suffering from chronic and complex conditions—like cancer, multiple sclerosis, and rheumatoid arthritis, or those recovering from organ transplants—can continue to access their specialty pharmacy providers without hindrance. Specialty pharmacies play an essential role in delivering care to vulnerable populations, and maintaining patient access to these services is paramount.
Leadership Support and Expectations
Sheila Arquette, NASP President and CEO, highlighted the critical function that specialty pharmacies serve for Medicare and Medicaid benefactors. She remarked, "Specialty pharmacies continue to receive reimbursement that fails to cover not just the drugs themselves but also the extensive services necessary for managing specialty patients. Protecting the access to specialty pharmacy services is crucial to ensuring continuity of care, improved health outcomes, and enabling patients to obtain the therapies they rely on safely and affordably."
Moving Forward with Urgency
NASP extends its gratitude to the Senate Finance Committee for their commitment to advancing this necessary legislation. The organization urges Congress to swiftly pass the bill, stating, "We thank them for their work to promote patient access to their pharmacy and encourage an expedited process for this long-awaited legislation."
What is NASP?
NASP represents the interests of all parties involved in the specialty pharmacy industry. These pharmacies are dedicated to serving communities affected by complex health issues, including cancer, rheumatoid arthritis, multiple sclerosis, cystic fibrosis, hemophilia, organ transplantations, and other rare diseases. Accredited by a recognized independent third-party organization, specialty pharmacies are committed to providing consistent quality in drug management and clinical patient care services.
Frequently Asked Questions
What is the main goal of the legislation supported by NASP?
The legislation aims to address anticompetitive practices that hinder beneficiary access to specialty pharmacies and ensure fair contract terms between these pharmacies and PBMs.
How does the legislation protect Medicare and Medicaid beneficiaries?
It mandates that contracts under Medicare Part D include reasonable terms and prohibits spread pricing in Medicaid, safeguarding patient access to essential medications.
Why are specialty pharmacies important for patients?
Specialty pharmacies play a crucial role in managing complex medical conditions and providing the necessary treatments that ensure continuity of care and better health outcomes for patients.
What is NASP's stance on the reimbursement model for specialty pharmacies?
NASP advocates for a reevaluation of the reimbursement models, which currently do not adequately cover the costs associated with specialty medications and the services required for patient care.
How can stakeholders support the proposed legislation?
Stakeholders can support the legislation by urging their Congressional representatives to prioritize and pass the bill promptly to enhance patient access to specialty pharmacy services.
